Seasoned Public Health Professional with over 25 years of experience designing, managing, and scaling high-impact health programs. Proven expertise in policy development, disease surveillance, and global health security. A WHO India Country Office veteran with 14 years of leadership, including extensive managerial and supervisory roles in disease surveillance, polio eradication, and epidemic preparedness efforts across different levels. Specializing in global health security, immunization, and health system strengthening, I have led successful multi-stakeholder collaborations, secured significant funding, and driven high-impact initiatives across diverse geographies. Proficient in managing multi-grant projects focused on strengthening immunizations under GAVI, USAID, and new business development. Adept at providing financial oversight, tracking deliverables, and submitting timely reports to ensure project success. I have a proven track record in stakeholder coordination, engaging national, state, and district leaders to ensure alignment with public health goals. This includes extensive work in facilitating Routine Immunization, Mission Indradhanush, COVID-19 vaccination, and Polio eradication programs. Key achievements: Developing COVID-19 vaccination operational guidelines and training materials, leading National Training of Trainers (ToT), and supporting GoI in providing ToT to other countries. Led immunization strategy reviews in priority states, facilitated the creation of state-specific coverage improvement plans, and spearheaded the development of Android-based tools for immunization reviews. Led the development of GIS-based immunization dashboards to enhance data visualization, monitoring, and program accountability. Contributing to the creation of national documents like "A Roadmap for Achieving 90% Full Immunization" and guidelines for the introduction of new vaccines. Leading technical support for introducing new vaccines, including assessing vaccine and cold chain requirements and ensuring effective monitoring and training for vaccine rollouts. Spearheading the Mucoprevalence Study of OPV and AFP surveillance reviews to identify gaps in surveillance systems and strengthen response strategies. As a strategic leader with a strong foundation in data-driven decision-making, I excel at developing and implementing strategies that enhance immunization coverage, strengthen health systems, and ensure the sustainability of public health interventions.